Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573261 · ClinicalTrials.gov registry record · Phase 4
A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00573261 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 40 participants.
The verdict
NCT00573261, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is designed to examine how pregabalin affects parameters of autonomic nerve regulation in correlation with change in pain, anxiety, and depressive symptoms in patients with diabetic neuropathy.
Interventions
- DRUG Placebo
- DRUG Pregabalin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00573261
The ClinicalTrials.gov registry entry for NCT00573261 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00573261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00573261 about?
NCT00573261 is a clinical study titled "A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy". This study is designed to examine how pregabalin affects parameters of autonomic nerve regulation in correlation with change in pain, anxiety, and depressive symptoms in patients with diabetic neuropathy.
What is the current status of trial NCT00573261?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2006-03. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00573261?
The interventions under investigation include: Placebo (DRUG), Pregabalin (DRUG).
Who is sponsoring clinical trial NCT00573261?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.